SCHEMBL7978087

SCHEMBL7978087

N#Cc1ccccc1OCCCCl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
GAA P10253 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 3/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 2/20 0.44
HPGD P15428 1/20 0.44
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
HTR1A P08908 2/20 0.43
POLB P06746 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
MAOA P21397 1/20 0.43
HTR2B P41595 1/20 0.43
TP53 P04637 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31096462 1.00 ALDH1A1 (0.54) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL3825769 0.93 ALDH1A1 (0.51) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL28711958 0.92 ALDH1A1 (0.54) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL10499090 0.84 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2GAAMAPK1
SCHEMBL29025260 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL13672851 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL1444254 0.83 CYP1A2 (0.55) ALDH1A1KDM4ESMN1; SMN2GAAMAPK1
SCHEMBL1942660 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL5987427 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2GAAMEN1
SCHEMBL1911338 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ESMN1; SMN2GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108069913-B Bis (morpholinylalkoxy) quinazoline derivative and application thereof in anti-tumor aspect 陕西师范大学 2022-03-01 CN disclosed
WO-2001066534-A2 CYCLIC AND BICYCLIC DIAMINO HISTAMINE-3 RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 2001-09-13 WO disclosed
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed
US-4950674-A Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment A. H. ROBINS COMPANY, INCORPORATED (US) 1990-08-21 US disclosed
US-4810713-A Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment A. H. ROBINS COMPANY, INCORPORATED (US) 1989-03-07 US disclosed
EP-0235463-A2 N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) (US) 1987-09-09 EP disclosed